piracetam has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peyrl, A | 1 |
| Weichert, N | 1 |
| Kühl, JS | 1 |
| Ebell, W | 1 |
| Hernáiz Driever, P | 1 |
1 other study available for piracetam and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Levetiracetam as a possible cause of secondary graft failure after allogenic hematopoietic stem cell transplantation.
Topics: Adolescent; Anticonvulsants; Blood Cell Count; Graft Rejection; Hematopoietic Stem Cell Transplantat | 2015 |